Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA, Networks W. Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 2014, 16: 909-914. PMID: 24919399, PMCID: PMC6281057, DOI: 10.1093/ntr/ntu087.Peer-Reviewed Original ResearchConceptsQuit attemptsQuit dateSmoking reductionEffective smoking cessation interventionsSubstantial public health burdenAid smoking cessationNicotine patch useSmoking cessation interventionPublic health burdenShort-acting formsNRT formulationsNRT medicationsRecalcitrant smokersNicotine patchCessation interventionsCigarette smokingSmoking cessationHealth burdenProvider consultationTobacco useDrug AdministrationRelapse preventionSmokersLabeling changesMonths